Synexus’ new research centre is expected to have the capacity for four full-time investigators, with an increase from 100 to 300 square metres of space and is also expected to include a wide range of diagnostic instruments to cover Synexus’ expanding therapy area coverage.
Synexus has been operating in Poland since 2006 from its site in Wroclaw and expanded its operations there in August 2009 with the acquisition of three new dedicated research centres in Warsaw, Gdynia and Katowice, following its takeover of CLCC.
Radoslaw Janiak, country manager for Poland, said: “We are able to recruit the right numbers of patients within the right time frame. The conference we organised in December has helped to raise awareness of the importance of clinical trials in Poland.”
Michael Fort, CEO of Synexus, said: “We are continuing to see increased levels of interest for clinical trials throughout the CEE, not least in Poland where our sites are located and staffed by qualified and experienced professionals.”